Bacterial selectivity and plausible mode of antibacterial action of designed Pro-rich short model antimicrobial peptides

Journal of Peptide Science

Volumn 14, Issue 7, 2008, Pages 876-882

  Park, Ka Hyon ^a   Park, Yoonkyung ^a   Park, Il Seon ^a,b   Hahm, Kyung Soo ^a,b   Shin, Song Yub ^a,b  

^a Chosun University   (South Korea)

^b Chosun University College of Medicine   (South Korea)

Author keywords

Bacterial selectivity; Indolicidin; Pro rich short model AMP; Therapeutic index

Indexed keywords

ANTIINFECTIVE AGENT; BUFORIN 2; INDOLICIDIN; POLYPEPTIDE ANTIBIOTIC AGENT; PROLINE;

ANTIBACTERIAL ACTIVITY; ARTICLE; BACTERIAL MEMBRANE; BINDING AFFINITY; DRUG BINDING; DRUG STRUCTURE; DRUG SYNTHESIS; DRUG TARGETING; HEMOLYSIS; HUMAN; HUMAN CELL; MEMBRANE DEPOLARIZATION; NONHUMAN; PRIORITY JOURNAL; PROTEIN LIPID INTERACTION; STAPHYLOCOCCUS AUREUS;

AMINO ACID SEQUENCE; ANTI-BACTERIAL AGENTS; DRUG DESIGN; ERYTHROCYTES; HEMOLYSIS; HUMANS; IONS; LIPOSOMES; MEMBRANE POTENTIALS; MODELS, BIOLOGICAL; PROLINE; STAPHYLOCOCCUS AUREUS;

BACTERIA (MICROORGANISMS); STAPHYLOCOCCUS AUREUS;

EID: 48249123462     PISSN: 10752617     EISSN: 10991387     Source Type: Journal    
DOI: 10.1002/psc.1019     Document Type: Article

References (30)

1. Boman HG. Peptide antibiotics and their role in innate immunity. Annu. Rev. Immunol. 1995; 13: 62-92.
2. Nicolas P, Mor A. Peptides as weapons against microorganisms in the chemical defense system of vertebrates. Annu. Rev. Microbiol. 1995; 49: 277-304.
3. Epand RM, Vogel HJ. Diversity of antimicrobial peptides and their mechanisms of action. Biochim. Biophys. Acta 1999; 1462: 11-28.
4. Zasloff M. Antimicrobial peptides of multicellular organisms. Nature 2002; 415: 389-395.
5. Bulet P, Stocklin R, Menin L. Anti-microbial peptides: from invertebrates to vertebrates. Immunol. Rev. 2004; 98: 169-184.
6. Tossi A, Sandri L, Giangaspero A. Amphipathic, α-helical antimicrobial peptides. Biopolymers 2000; 55: 4-30.
7. Giangaspero A, Tossi A, Sandri L. Amphipathic α-helical antimicrobial peptides. Eur. J. Biochem. 2001; 268: 5589-5600.
8. Lehrer RI, Lichtenstein AK, Ganz T. Defensins: antimicrobial and cytotoxic peptides of mammalian cells. Annu. Rev. Immunol. 1993; 11: 105-128.
9. Sokolov Y, Mirzabekov T, Martin DW, Lehrer RI, Kagan BL. Membrane channel formation by antimicrobial protegrins. Biochim. Biophys. Acta 1999; 1420: 23-29.
10. Chan DI, Prenner EJ, Vogel HJ. Tryptophan- and arginine-rich antimicrobial peptides: structures and mechanisms of action. Biochim. Biophys. Acta 2006; 1758: 1184-1202.
11. Schibli DJ, Epand RF, Vogel HJ, Epand RM. Tryptophan-rich antimicrobial peptides: comparative properties and membrane interactions. Biochem. Cell Biol. 2002; 80: 667-677.
12. Schibli DJ, Hwang PM, Vogel HJ. Structure of the antimicrobial peptide tritrpticin bound to micelles: a distinct membrane-bound peptide fold. Biochemistry 1999; 38: 16749-16755.
13. Yang ST, Shin SY, Lee CW, Kim YC, Hahm KS, Kim JI. Selective cytotoxicity following Arg-to-Lys substitution in tritrpticin adopting a unique amphipathic turn structure. FEBS Lett. 2003; 540: 229-233.
14. Zhu WL, Hahm KS, Shin SY. Cathelicidin-derived Trp/Pro-rich antimicrobial peptides with lysine peptoid residue (Nlys): therapeutic index and plausible mode of action. J. Pept. Sci. 2007; 13: 529-535.
15. Lawyer C, Pai S, Watabe M, Borgia P, Mashimo T, Eagleton L, Watabe K. Antimicrobial activity of a 13 amino acid tryptophan-rich peptide derived from a putative porcine precursor protein of a novel family of antibacterial peptides. FEBS Lett. 1996; 390: 95-98.
16. Subbalakshmi C, Bikshapathy E, Sitaram N, Nagaraj R. Antibacterial and hemolytic activities of single tryptophan analogs of indolicidin. Biochem. Biophys. Res. Commun. 2000; 274: 714-716.
17. Fields GB, Noble RL. Solid phase peptide synthesis utilizing 9-fluorenylmethoxycarbonyl amino acids. Int. J. Pept. Protein Res. 1990; 35: 161-214.
18. Yang ST, Shin SY, Hahm KS, Kim JI. Design of perfectly symmetric Trp-rich peptides with potent and broad-spectrum antimicrobial activities. Int. J. Antimicrob. Agents 2006; 27: 325-330.
19. Song YM, Park Y, Lim SS, Yang ST, Woo ER, Park IS, Lee JS, Kim JI, Hahm KS, Kim Y, Shin SY. Cell selectivity and mechanism of action of antimicrobial model peptides containing peptoid residues. Biochemistry 2005; 44: 12094-12106.
20. Song YM, Yang ST, Lim SS, Kim Y, Hahm KS, Kim JI, Shin SY. Effects of L- or D-Pro incorporation into hydrophobic or hydrophilic helix face of amphipathic α-helical model peptide on structure and cell selectivity. Biochem. Biophys. Res. Commun. 2004; 314: 615-621.
21. Mao D, Wallace BA. Differential light scattering and absorption flattening optical effects are minimal in the circular dichroism spectra of small unilamellar vesicles. Biochemistry 1984; 23: 2667-2673.
22. Shai Y, Bach D, Yanovsky A. Channel formation properties of synthetic pardaxin and analogues. J. Biol. Chem. 1990; 265: 20202-20209.
23. Wu M, Hancock RE. Interaction of the cyclic antimicrobial cationic peptide bactenecin with the outer and cytoplasmic membrane. J. Biol. Chem. 1999; 274: 29-35.
24. Friedrich CL, Moyles D, Beveridge TJ, Hancock RE. Antibacterial action of structurally diverse cationic peptides on gram-positive bacteria. Antimicrob. Agents Chemother. 2000; 44: 2086-2092.
25. Powers JP, Rozek A, Hancock RE. Structure-activity relationships for the β-hairpin cationic antimicrobial peptide polyphemusin I. Biochim. Biophys. Acta 2004; 1698: 239-250.
26. Chen Y, Mant CT, Farmer SW, Hancock RE, Vasil ML, Hodges RS. Rational design of α-helical antimicrobial peptides with enhanced activities and specificity/therapeutic index. J. Biol. Chem. 2005; 280: 12316-12329.
27. Fazio MA, Jouvensal L, Vovelle F, Bulet P, Miranda MT, Daffre S, Miranda A. Biological and structural characterization of new linear gomesin analogues with improved therapeutic indices. Biopolymers 2007; 88: 386-400.
28. Park CB, Kim HS, Kim SC. Mechanism of action of the antimicrobial peptide buforin II: buforin II kills microorganisms by penetrating the cell membrane and inhibiting cellular functions. Biochem. Biophys. Res. Commun. 1998; 244: 253-257.
29. Park CB, Yi KS, Matsuzaki K, Kim MS, Kim SC. Structure-activity analysis of buforin II, a histone H2A-derived antimicrobial peptide: the proline hinge is responsible for the cell-penetrating ability of buforin II. Proc. Natl. Acad. Sci U.S.A. 2000; 97: 8245-8250.
30. Kobayashi S, Chikushi A, Tougu S, Imura Y, Nishida M, Yano Y, Matsuzaki K. Membrane translocation mechanism of the antimicrobial peptide buforin 2. Biochemistry 2004; 43: 15610-15616.